WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2018> 21> 1

Volume: 21 Issue: 1

1. Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy--
AKT/m-TOR Pathway and Resistance to Cancer Therapy. Page:63—66
2. Research Progress in the Therapeutic Strategy Based on Targeting at 
Lung Cancer Stem Cell. Page:57—62
3. Circular RNA in Lung Cancer Research: Biogenesis, Functions and Roles. Page:50—56
4. Progress of Long Non-coding RNA in Non-small Cell Lung Cancer. Page:43—49
5. Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer. Page:37—42
6. Epidemiological Evolution of Lung Cancer in the South of Spain from 1990 to 2010. Page:32—36
7. Surgical Procedures and Perioperative Management for Non-small Cell Lung Cancer Complicated with Left Atrial Tumor Thrombus. Page:24—31
8. Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion. Page:16—23
9. Prognostic Analysis of Lobectomy versus Sublobar Resection in Patients Aged ≥60 Years with Stage Ia Small Cell Lung Cancer. Page:8—15
10. Clinical Study on the Prognosis of Patients with Thymoma with Myasthenia Gravis. Page:1—7

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.